Thames Water halts bosses' bonus scheme

Scientists have kicked off a groundbreaking—and highly debated—project to synthesize artificial human DNA from scratch. It's being called a world-first effort to construct the fundamental components of human life in a lab, raising big ethical and scientific questions.

Editor’s Note: This isn't just another lab experiment—it’s pushing the boundaries of what’s possible in genetic engineering. While it could lead to breakthroughs in medicine or synthetic biology, it also forces us to ask: Should we be playing architect with human DNA? The debate around ethics, safety, and unintended consequences is about to get a lot louder.

A Russian scientist and Harvard researcher, Kseniia Petrova, has been indicted by a grand jury for allegedly smuggling undeclared scientific samples into the U.S. She was detained back in February but recently appeared in federal court in Boston with her lawyers after being released.

Editor’s Note: This isn’t just about a paperwork slip-up—it raises serious questions about international scientific collaboration and security. If proven, smuggling sensitive materials could strain research partnerships and heighten scrutiny on foreign scientists working in the U.S. At the same time, it’s a reminder of how easily legal missteps can derail careers, even for respected researchers.

UK health officials are investigating potential side effects of popular weight loss and diabetes injections after hundreds of users reported pancreas issues, including some fatal cases of pancreatitis. The study focuses on GLP-1 medications, which have gained widespread use but may carry serious risks.

Editor’s Note: These injections have been game-changers for many managing diabetes or obesity, but emerging reports of severe pancreas complications—some deadly—raise urgent questions. It’s not a call to panic, but a reminder that even breakthrough drugs need careful monitoring, especially as demand skyrockets. If you’re on these meds, this is worth discussing with your doctor, not ditching treatment outright.

Robert F. Kennedy Jr. is calling out Gavi, a major global vaccine organization, claiming they're disregarding scientific evidence in their policies. While he didn’t specify which science he believes is being ignored, his criticism adds fuel to ongoing debates about vaccine transparency and trust in public health institutions.

Robert F. Kennedy Jr., the independent presidential candidate known for his controversial stance on vaccines, has selected a team of advisers to shape his vaccine policies. This group—largely composed of like-minded skeptics—is meeting for the first time, signaling a potential push to center vaccine skepticism in his campaign.